Skip to content

Understanding long term consequences of respiratory viral infection 2260810

Jul 2026 · Journal of Immunology · Vol 215 · 0 citations

TL;DR

The findings suggest that severe respiratory viral insult can imprint durable remodeling of circulating immunity, and identifying the specific transcriptional signatures and upstream mediators may reveal targets to restore immune balance and resilience during age.

Abstract

In the wake of the SARS-CoV-2 pandemic, most people have experienced at least one respiratory viral infection and many endured severe disease, yet the long term immune consequences remain unclear. We hypothesized that severe infection episode durably reshapes circulating immunity and accelerates age-like change. To enable within-animal longitudinal inference, we focused on blood so the same mice could be profiled over time. Wild type mice received sublethal influenza A virus (IAV) or mock, and whole blood single-cell RNA-seq of PBMCs was performed at 2, 4, 8, and 14 months post infection from the same animals. Severe IAV was associated with a progressive rise in the neutrophil-to-lymphoid ratio (NLR) from 2-14 months versus mock, with concomitant declines in naïve B and T cells. A GZMK+ CD8 T-cell subset increased in frequency and activation state in infected mice. These features paralleled aging like myeloid bias programs, consistent with infection accelerated immunosenescence. Ongoing analyses use batch aware mixed effects models and gene set scoring to define cell-state programs linked to NLR and GZMK+ CD8 expansion. Our findings suggest that severe respiratory viral insult can imprint durable remodeling of circulating immunity, identifying the specific transcriptional signatures and upstream mediators may reveal targets to restore immune balance and resilience during age. n/a Viral Immunology (VIR)

View source

Similar papers

Open access Jul 2026

Persistent expression of myeloid lineage markers in resident and circulating T cells induced by SARS-CoV-2 infection 2328943

CD11b, CD11c expressing CD4/CD8 T cell subsets with potent antiviral effects are characterized, which is in accord with the reported data of association of CD11b and CD11c T cell with increased cytotoxic activity in other viral infections like Influenza, RSV.

Divyasha Saxena, Jian Zheng · 0 citations
Aug 2026

A Time-Resolved Single-Cell Atlas Reveals Infection-Status, Age-, and Sex-Dependent Immune Responses Drive Viral Disease Severity

Time-resolved single-cell RNA sequencing across 16 conditions spanning age, sex, and four stages of influenza infection in mice generates a high-resolution atlas, revealing how infection status of the cell, age, and sex interact to drive persistent inflammation and impaired resolution.

Lu-Jia Chen, Aodong Qiu, Jooyoung Kim et al. · 0 citations
Open access Jul 2026

Elevated type I interferon levels during Influenza virus infection profoundly suppress pulmonary innate and adaptive immunity and exacerbate disease 2257518

Most mouse studies aimed at investigating the roles of specific cytokines in disease states use mice deficient for the cytokine or its receptor, or antibody treatment to block its signaling. While such analyses have found relatively minor impacts for type I interferon (IFN-I) signals during Influenza A (IAV) infe...

E. Baffoe, Kunal Dhume, K. McKinstry · 0 citations
Open access Sep 2026

Progressive Post-Acute Gut Microbiome Disruption Following SARS-CoV-2 Infection in Mice

SARS-CoV-2 infection is increasingly recognized to produce long-lasting physiological disturbances that extend beyond the acute phase. The gut microbiome has emerged as a potential contributor to post-infection outcomes, yet the longitudinal progression of microbial disruption following infection remains poorly defined...

Ritu Mann-Nüttel, N. Ogando, Marie Armbruster et al. · 0 citations
Aug 2026

Lineage-specific pulmonary transcriptome landscape of coronavirus infection unveils universal immunotherapy for viral pneumonia.

It is demonstrated that a rational combination of pharmacological targeting of innate and adaptive immune responses is sufficient to reduce mortality and severe illness caused by beta, delta and EG.1 variants in SARS-CoV-2 infection.

Ming Zhou, Xuan Liu, Haiqing Xiao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.